# Donepezil 10 mg Tablets Under Fed Conditions

> **NCT01439243** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Aricept®

## Key facts

- **NCT ID:** NCT01439243
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2011-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01439243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01439243, "Donepezil 10 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01439243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*